Edward Sheldon has many years until retirement, so his SIPP is invested in high-quality growth stocks and funds that have ...

Ahead of their listing, the unlisted shares of the company were trading with around 27% GMP over IPO price at Rs 114-115 apiece in the grey market.

Recession expectations are starting to fall away. Stephen Wright’s looking at what this means for the stock market and where ...

Ceasefire negotiations between Russia and Ukraine may soon be under way, but Ukraine’s economic recovery will be hobbled unless the European Union fast-tracks the war-torn country’s membership and ...

Monolithic Power Systems' historical valuation multiples are high, but justified by its consistent growth and strong business ...

There are 5 “W”s that don’t always make it into mainstream financial conversations but have the power to yield exponential returns over time. These are unconventional investments that don’t require a ...

Pivoting away from US exposure could help investors to hedge against the possible negative effects of Trump's tariffs.

The grimacing toys aren't the average collector's item, but they have quickly become the latest accessory for fashionistas.

Japan’s Prime Minister Shigeru Ishiba said Friday that he held telephone talks with U.S. President Donald Trump and agreed to hold “productive” discussions at an upcoming ...

While NSEs IPO has been in the works since 2016, the sheer number of investors having interest in shares of the company ...

Get all latest & breaking news on Emcure Pharmaceuticals. Watch videos, top stories and articles on Emcure Pharmaceuticals at moneycontrol.com.

Economists and MPs had their own nicknames and thoughts to share. Bagrie Economics managing director Cameron Bagrie called it ...